Skip to main content

Pharmacokinetic Modeling and the Teratologist

  • Chapter
Teratogenesis and Reproductive Toxicology

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 65))

  • 190 Accesses

Abstract

Pharmacokinetics has proven to be an exceptional tool in pharmaceutical and pharmacologic research. Its development has enhanced the capabilities of providing optimum dosing schedules and formulations for delivery of ethical drugs by relating blood levels of a particular drug to its therapeutic efficacy. Likewise, perturbations in the pharmacokinetic parameters of a compound produced by interactions with a second chemical or with fiver or kidney insufficiency, for example, have provided a more logical basis for the study of drug-drug or drug-chemical interactions, as well as effects of disease states in clinical pharmacology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Barr WH (1969) Factors involved in the assessment of systemic or biologic availability of drug products. Drug Inf Bull 3:27

    Google Scholar 

  • Berlin NI, Berman M, Berk PD, Phang JM, Waldmann TA (1968) The application of multicompartmental analysis to problems of clinical medicine, Ann Intern Med 68:423

    PubMed  CAS  Google Scholar 

  • Cutler DJ (1978) On the definition of the compartment concept in pharmacokinetics. J Theor Biol 73:329

    Article  PubMed  CAS  Google Scholar 

  • Dost FH (1953) Der Blutspiegel: Kinetic der Konzentrations-aublaute in der Kreislaufflüssigkeit. G Thieme, Leipzig

    Google Scholar 

  • Dost FH (1958) Klin Wochschr 36:665

    Article  Google Scholar 

  • Feldman S (1974) Drug distribution, Med Clin North Am 58:917

    PubMed  CAS  Google Scholar 

  • Garrett ER (1969) Basic concepts and experimental methods of pharmacokinetics. Adv Biosci 5:7

    CAS  Google Scholar 

  • Garrett ER (1970) Clinical significance of pharmacokinetics. In: Dengler HJ (ed) Pharmacological and clinical significance of pharmacokinetics, Symposia in medica Hoechst, F.K. Schaffauer-Verlag, Stuttgart New York pp. 5–21

    Google Scholar 

  • Garrett ER (1973) Classical pharmacokinetics to the frontier. J Pharmacokinet Biopharm 1:341

    Article  PubMed  CAS  Google Scholar 

  • Garrett ER, Johnston RL, Collins EJ (1962) Kinetics of steroid effects on Ca47 dynamics in dogs with the analog computer. I. J Pharm Sci 51:1050

    Article  CAS  Google Scholar 

  • Garrett ER, Johnston RL, Collins EJ (1963) Kinetics of steroid effects on Ca47 dynamics in dogs with the analog computer. II. J Pharm Sci 52:668

    Article  PubMed  CAS  Google Scholar 

  • Garrett ER, Bres J, Schnelle K, Rolf LL Jr (1974) Pharmacokinetics of saturably metabolized amobarbital. J Pharmacokinet Biopharm 2:43

    Article  CAS  Google Scholar 

  • Gibaldi M (1971) Pharmacokinetic aspects of drug metabolism. Ann NY Acad Sei 179:19

    Article  CAS  Google Scholar 

  • Gibaldi M, Feldman S (1969) Pharmacokinetic basis for the influence of route of administration on the area under the plasma concentration-time curve. J Pharm Sci 58:1477

    Article  PubMed  CAS  Google Scholar 

  • Gibaldi M, Levy G, Weintraub H (1971) Drug distribution and pharmacologic effects. Clin Pharmacol Ther 12:734

    PubMed  CAS  Google Scholar 

  • Haley TJ, Young JF (1978) A pharmacokinetic study of pentachlorophenol poisoning and the effects of forced diuresis. Clin Toxicol 12:41

    Article  PubMed  Google Scholar 

  • Harris PA, Riegelman S (1969) Influence of the route of administration on the area under the plasma concentration-time curve. J Pharm Sci 58:71

    Article  PubMed  CAS  Google Scholar 

  • Himmelstein KJ, Lutz RJ (1979) A review of the applications of physiologically based pharmacokinetic modeling. J Pharmacokin et Biopharm 7:127

    Article  CAS  Google Scholar 

  • Holson JF, Kimmel CA, Young JF (1980) The precision of pharmacokinetic parameters for predicting embryotoxicity endpoints. [Abstr] Presented at the 19th Annual Meeting of the Society of Toxicology, Washington DC, March 10, 1950

    Google Scholar 

  • Houston J, Levy BG (1976) Effect of route of administration on competitive drug biotransformation interaction: salicylamide ascorbic acid interaction in rat. J Pharmacol Exp Ther 198:284

    PubMed  CAS  Google Scholar 

  • Hull CJ (1979) Symbols for compartmental models. Br J Anaesth 51:815

    Article  Google Scholar 

  • Jusko WJ (1972) Pharmacodynamic principles in chemical teratology: dose-effect relationships. J Pharmacol Exp Ther 183:469

    PubMed  CAS  Google Scholar 

  • Kaplan SA, Jack ML, Cotler S, Alexander K (1973) Utilization of area under curve to elucidate the disposition of an extensively biotransformed drug. J Pharmacokinet Biopharm 1:201

    Article  CAS  Google Scholar 

  • Leferink JG, Maes RAA (1979) STRIPACT, an interactive curve fit programme for pharmacokinetic analyses. Arzneim Forsch 29:1894

    CAS  Google Scholar 

  • Levy G (1974 a) Pharmacokinetic control and clinical interpretation of steady-state blood levels of drugs. Clin Pharmacol Ther 16:130

    CAS  Google Scholar 

  • Levy G (1974 b) An orientation to clinical pharmacokinetics. In: Levy G (ed) Clinical pharmacokinetics -a symposium. American Pharmaceutical Association, Academy of Pharmaceutical Sciences, Washington D. C. pp. 1–9

    Google Scholar 

  • Levy G (1976) Pharmacokinetic approaches to the study of drug interactions. Ann NY Acad Sci 281:24

    Article  PubMed  CAS  Google Scholar 

  • Levy G, Gibaldi M, Jusko WJ (1969) Multi-compartment pharmacokinetic models and pharmacologic effects. J Pharm Sci 58:422

    Article  PubMed  CAS  Google Scholar 

  • Niebergall PJ, Sugita ET, Schnaare RL (1974) Calculation of plasma level versus time profiles for variable dosing regimens. J Pharm Sci 63:100

    Article  PubMed  CAS  Google Scholar 

  • Nogami H, Hanano M, Awazu S, Moon HH (1969) Pharmacokinetic analysis on the disappearance of ethoxybenzamide from plasma. Statistical treatment of data of two compartmental model by a digital computer. Chem Pharm Bull (Tokyo) 17:2097

    PubMed  CAS  Google Scholar 

  • Nooney GC (1966) Mathematical models in medicine: a diagnosis. J Chronic Dis 19:325

    Article  PubMed  CAS  Google Scholar 

  • Notari RE (1973) Pharmacokinetics and molecular modification: implications in drug design and evaluation. J Pharm Sci 62:865

    Article  PubMed  CAS  Google Scholar 

  • Pedersen PV (1977) Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. J Pharmacokinet Biopharm 5:513

    Article  PubMed  CAS  Google Scholar 

  • Ramsey JC, Gehring PJ (1980) Application of pharmacokinetic principles in practice. Fed Proc 39:60

    PubMed  CAS  Google Scholar 

  • Ritschel WA (1970) Biological half-lives of drugs. Drug Intell Clin Pharm 4:332

    CAS  Google Scholar 

  • Runner MN (1967) Comparative pharmacology in relation to teratogenesis. Fed Proc 26:1131

    PubMed  CAS  Google Scholar 

  • Sedman AJ, Wagner JG (1974a) Quantitative pooling of Michaelis-Menten equations in models with parallel metabolite formation paths. J Pharmacokinet Biopharm 2:149

    Article  PubMed  CAS  Google Scholar 

  • Sedman AJ, Wagner JG (1974 b) Importance of use of appropriate pharmacokinetic model to analyze in vivo enzyme constants. J Pharmacokinet Biopharm 2:161

    Article  PubMed  CAS  Google Scholar 

  • Sedman AJ, Wagner JG (1974 c) AUTOAN manual. Publication Distribution Service, Ann Arbor, Michigan

    Google Scholar 

  • Seman AJ, Wagner JG (1976) CSTRIP, a Fortran IV computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 65:1006

    Article  Google Scholar 

  • Smyth RD, Hottendorf GH (1980) Application of pharmacokinetics and biopharmaceutics in the design of toxicological studies. Toxicol Appl Pharmacol 53:179–195

    Article  PubMed  CAS  Google Scholar 

  • Taylor JD, Wiegand RG (1962) The analog computer and plasma drug kinetics. Clin Pharmacol Ther 3:464

    PubMed  CAS  Google Scholar 

  • Tilstone WJ, Winchester JF, Reavey PC (1979) The use of pharmacokinetic principles in determining the effectiveness of removal of toxins from blood. Clin Pharmacokinet 4:23

    Article  PubMed  CAS  Google Scholar 

  • Wagner JG (1968 a) Pharmacokinetics. 3. Half-life and volume of distribution. Drug Intell 2:126

    CAS  Google Scholar 

  • Wagner JG (1968 b) Pharmacokinetics. 4. Body water compartments and the distribution of drugs. Drug Intell 2:158

    Google Scholar 

  • Wagner JG (1971) “Biopharmaceutics and relevant pharmacokinetics.” Drug Intelligence Publications, Hamilton, Illinois

    Google Scholar 

  • Wagner JG (1973) A modern view of pharmacokinetics. J Pharmacokinet Biopharm 1:363

    Article  PubMed  CAS  Google Scholar 

  • Wagner JG (1976) Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances. Eur J Clin Pharmacol 20:425

    Article  Google Scholar 

  • White CG, Young JF, Holson JF (1980) Pharmacokinetic approach to analysis of the “window effect” in teratologic sensitivity [Abstr]. Presented at the 19th Annual Meeting of the Society of Toxicology, Washington, D.C., March 10, 1980

    Google Scholar 

  • Young JF, Haley TJ (1977) Pharmacokinetic study of a patient intoxicated with 2,4-dichlorophenoxyatic acid and 2-methoxy-3,4-dichlorobenzoic acid. Clin Toxicol 11:489

    Article  PubMed  CAS  Google Scholar 

  • Young JF, Holson JF (1978) Utility of pharmacokinetics in designing toxicological protocols and improving interspecies extrapolation. J Environ Pathol Toxicol 2:169

    PubMed  CAS  Google Scholar 

  • Young JF, Kimmel CA, Holson JF (1979) Validation of a pharmacokinetic model for rat embryonal dosimetry of salicylates during a tertogenically susceptible period. Toxicol Appl Pharmacol 48:A21

    Google Scholar 

  • Zettner A (1973) Principles of competitive binding assays (saturation analyses). I. Equilibrium techniques. Clin Chem 19:699

    PubMed  CAS  Google Scholar 

  • Zettner A, Duly PE (1974) Principles of competitive binding assays (saturation analyses). II. Sequential saturation. Clin Chem 20:5

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Young, J.F. (1983). Pharmacokinetic Modeling and the Teratologist. In: Johnson, E.M., Kochhar, D.M. (eds) Teratogenesis and Reproductive Toxicology. Handbook of Experimental Pharmacology, vol 65. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81919-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81919-3_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81921-6

  • Online ISBN: 978-3-642-81919-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics